Acadian Asset Management LLC Buys 72,781 Shares of Encompass Health Corporation $EHC

Acadian Asset Management LLC increased its position in Encompass Health Corporation (NYSE:EHC) by 207.1% in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 107,929 shares of the company’s stock after acquiring an additional 72,781 shares during the quarter. Acadian Asset Management LLC owned about 0.11% of Encompass Health worth $13,226,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Congress Asset Management Co. purchased a new stake in shares of Encompass Health in the second quarter worth about $92,691,000. Nuveen LLC purchased a new stake in shares of Encompass Health in the first quarter worth $50,665,000. T. Rowe Price Investment Management Inc. boosted its stake in Encompass Health by 25.6% during the first quarter. T. Rowe Price Investment Management Inc. now owns 2,080,918 shares of the company’s stock valued at $210,756,000 after buying an additional 424,691 shares during the period. Strs Ohio purchased a new position in Encompass Health during the first quarter worth about $34,364,000. Finally, American Century Companies Inc. boosted its position in shares of Encompass Health by 78.6% during the 1st quarter. American Century Companies Inc. now owns 723,169 shares of the company’s stock valued at $73,243,000 after acquiring an additional 318,251 shares during the last quarter. Institutional investors own 97.25% of the company’s stock.

Wall Street Analysts Forecast Growth

EHC has been the subject of a number of research reports. UBS Group increased their price target on shares of Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Thursday, October 2nd. KeyCorp boosted their price objective on shares of Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a report on Tuesday, September 16th. Bank of America raised their price objective on Encompass Health from $145.00 to $160.00 and gave the company a “buy” rating in a research note on Wednesday, September 10th. Zacks Research raised Encompass Health from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, October 21st. Finally, Raymond James Financial raised Encompass Health to a “strong-buy” rating in a research note on Friday, October 31st. Three analysts have rated the stock with a Strong Buy rating and eight have assigned a Buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $142.86.

Insider Activity

In other news, EVP Patrick William Tuer sold 1,020 shares of the stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total value of $126,061.80. Following the completion of the transaction, the executive vice president owned 18,846 shares of the company’s stock, valued at approximately $2,329,177.14. This represents a 5.13% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 2.00% of the company’s stock.

Encompass Health Stock Performance

NYSE:EHC opened at $115.62 on Wednesday. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.76. The firm’s fifty day simple moving average is $123.25 and its 200 day simple moving average is $119.75. The stock has a market cap of $11.63 billion, a P/E ratio of 21.86, a price-to-earnings-growth ratio of 2.20 and a beta of 0.91. Encompass Health Corporation has a twelve month low of $87.85 and a twelve month high of $127.99.

Encompass Health (NYSE:EHC) last posted its earnings results on Wednesday, March 16th. The company reported $0.93 EPS for the quarter. Encompass Health had a net margin of 9.33% and a return on equity of 18.19%. The firm had revenue of $136.30 million during the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. As a group, research analysts predict that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be issued a dividend of $0.19 per share. The ex-dividend date is Friday, January 2nd. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio is 14.37%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.